Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Double

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Aug 29, 2024 10:30am

301 Views

Post# 36201118

Double

Been at this a long time but aside from some of the unrealistic early days of the MJ stocks, at just over a month, this is one of the fastest doubles I have seen. Kicking myself because I was a bit leery of the markets so sold 30% of my holdings around the mid $12's. While anytime you book a profit is good, in this case, it's just annoying. LOL

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland